Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk E Muller

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Therapeutic Drug Monitoring|November 13, 2021
Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical OutcomeBirgit C P Koch, Anouk E Muller, Nicole G M Hunfeld, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2026
The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection modelsSanne van den Berg, Michel Pieren, Sebastiaan D T Sassen, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2025
The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniaeSanne Van Den Berg, Sebastiaan D T Sassen, William Couet, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based DosingEveline E Roelofsen, Brenda C M de Winter, Heleen van der Spek, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover studyAngela Huttner, Rixt A Wijma, Andrew J Stewardson, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2023
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection modelsAart van der Meijden, Vincent Aranzana-Climent, Heleen van der Spek, et al.
British Journal of Clinical Pharmacology|August 9, 2022
Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic studyEveline E Roelofsen, Alan Abdulla, Anouk E Muller, et al.
European Journal of Clinical Pharmacology|April 21, 2020
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patientsAlan Abdulla, Omar Rogouti, Nicole G M Hunfeld, et al.
Critical Care (London, England)|September 16, 2020
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)Alan Abdulla, Annemieke Dijkstra, Nicole G M Hunfeld, et al.
International Journal of Antimicrobial Agents|January 10, 2025
An integrative and translational PK/PD modelling approach to explore the combined effect of polymyxin B and minocycline against Klebsiella pneumoniaeChenyan Zhao, Sanne van den Berg, Zhigang Wang, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|November 13, 2021
Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical OutcomeBirgit C P Koch, Anouk E Muller, Nicole G M Hunfeld, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2026
The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection modelsSanne van den Berg, Michel Pieren, Sebastiaan D T Sassen, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2025
The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniaeSanne Van Den Berg, Sebastiaan D T Sassen, William Couet, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based DosingEveline E Roelofsen, Brenda C M de Winter, Heleen van der Spek, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover studyAngela Huttner, Rixt A Wijma, Andrew J Stewardson, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2023
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection modelsAart van der Meijden, Vincent Aranzana-Climent, Heleen van der Spek, et al.
British Journal of Clinical Pharmacology|August 9, 2022
Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic studyEveline E Roelofsen, Alan Abdulla, Anouk E Muller, et al.
European Journal of Clinical Pharmacology|April 21, 2020
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patientsAlan Abdulla, Omar Rogouti, Nicole G M Hunfeld, et al.
Critical Care (London, England)|September 16, 2020
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)Alan Abdulla, Annemieke Dijkstra, Nicole G M Hunfeld, et al.
International Journal of Antimicrobial Agents|January 10, 2025
An integrative and translational PK/PD modelling approach to explore the combined effect of polymyxin B and minocycline against Klebsiella pneumoniaeChenyan Zhao, Sanne van den Berg, Zhigang Wang, et al.
Pageof 7